Fair Value (Tables)
|
3 Months Ended |
Mar. 31, 2022 |
Fair Value Disclosures [Abstract] |
|
Assets And Liabilities Measured At Fair Value On A Recurring Basis |
The following table presents assets and liabilities measured at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at March 31, 2022 using: | (In thousands) | | Level 1 | | Level 2 | | Level 3 | | Balance at March 31, 2022 | Assets | | | | | | | | | Investment securities: | | | | | | | | | Obligations of U.S. Treasury and other U.S. Government sponsored entities | | $ | — | | | $ | 38,562 | | | $ | — | | | $ | 38,562 | | Obligations of states and political subdivisions | | — | | | 371,641 | | | — | | | 371,641 | | U.S. Government sponsored entities’ asset-backed securities | | — | | | 834,802 | | | — | | | 834,802 | | Collateralized loan obligations | | — | | | 494,917 | | | — | | | 494,917 | | Corporate debt securities | | — | | | 17,225 | | | — | | | 17,225 | | Equity securities | | 1,546 | | | — | | | 491 | | | 2,037 | | Mortgage loans held for sale | | — | | | 7,852 | | | — | | | 7,852 | | Mortgage IRLCs | | — | | | 301 | | | — | | | 301 | | Loan interest rate swaps | | — | | | 923 | | | — | | | 923 | | | | | | | | | | | Liabilities | | | | | | | | | Fair value swap | | $ | — | | | $ | — | | | $ | 226 | | | $ | 226 | | Borrowing interest rate swap | | — | | | 86 | | | — | | | 86 | | Loan interest rate swaps | | — | | | 923 | | | — | | | 923 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at December 31, 2021 using: | (In thousands) | | Level 1 | | Level 2 | | Level 3 | | Balance at December 31, 2021 | Assets | | | | | | | | | Investment securities: | | | | | | | | | Obligations of states and political subdivisions | | $ | — | | | $ | 389,591 | | | $ | — | | | $ | 389,591 | | U.S. Government sponsored entities’ asset-backed securities | | — | | | 854,463 | | | — | | | 854,463 | | Collateralized loan obligations | | — | | | 498,674 | | | — | | | 498,674 | | Corporate debt securities | | — | | | 11,412 | | | — | | | 11,412 | | Equity securities | | 1,630 | | | — | | | 499 | | | 2,129 | | Mortgage loans held for sale | | — | | | 9,387 | | | — | | | 9,387 | | Mortgage IRLCs | | — | | | 333 | | | — | | | 333 | | Loan interest rate swaps | | — | | | 1,952 | | | — | | | 1,952 | | | | | | | | | | | Liabilities | | | | | | | | | Fair value swap | | $ | — | | | $ | — | | | $ | 226 | | | $ | 226 | | Borrowing interest rate swap | | — | | | 262 | | | — | | | 262 | | Loan interest rate swaps | | — | | | 1,952 | | | — | | | 1,952 | |
|
Reconciliation Of Level 3 Input For Financial Instruments Measured On Recurring Basis |
The table below presents a reconciliation of the beginning and ending balances of the Level 3 inputs for the three-month periods ended March 31, 2022 and 2021, for financial instruments measured on a recurring basis and classified as Level 3:
| | | | | | | | | | | | | | | Level 3 Fair Value Measurements | Three months ended March 31, 2022 and 2021 | (In thousands) | | Equity Securities | | Fair value swap | Balance at January 1, 2022 | | $ | 499 | | | $ | (226) | | Total losses | | | | | Included in other income | | (8) | | | — | | Balance at March 31, 2022 | | $ | 491 | | | $ | (226) | | | | | | | Balance at January 1, 2021 | | $ | 485 | | | $ | (226) | | Total gains | | | | | Included in other income | | 5 | | | — | | Balance at March 31, 2021 | | $ | 490 | | | $ | (226) | |
|
Assets And Liabilities Measured At Fair Value On A Nonrecurring Basis |
The following tables present assets and liabilities measured at fair value on a nonrecurring basis. Individually evaluated collateral dependent loans secured by real estate are carried at fair value if they have been charged down to fair value or if a specific valuation allowance has been established. As of March 31, 2022 and December 31, 2021, there were no PCD loans carried at fair value. A new cost basis is established at the time a property is initially recorded in OREO. OREO properties are carried at fair value if a devaluation has been taken with respect to the property's value subsequent to the initial measurement.
| | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at March 31, 2022 using: | (In thousands) | | Level 1 | | Level 2 | | Level 3 | | Balance at March 31, 2022 | Individually evaluated collateral dependent loans recorded at fair value: | | | | | | | | | Commercial real estate | | $ | — | | | $ | — | | | $ | 566 | | | $ | 566 | | Residential real estate | | — | | | — | | | 261 | | | 261 | | Total individually evaluated collateral dependent loans recorded at fair value | | $ | — | | | $ | — | | | $ | 827 | | | $ | 827 | | | | | | | | | | | MSRs | | $ | — | | | $ | 14,021 | | | $ | — | | | $ | 14,021 | | | | | | | | | | | OREO recorded at fair value: | | | | | | | | | Residential real estate | | — | | | — | | | 760 | | | 760 | | Total OREO recorded at fair value | | $ | — | | | $ | — | | | $ | 760 | | | $ | 760 | | | | | | | | | | | Other repossessed assets | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at December 31, 2021 using: | (In thousands) | | Level 1 | | Level 2 | | Level 3 | | Balance at December 31, 2021 | Individually evaluated collateral dependent loans recorded at fair value: | | | | | | | | | Commercial real estate | | $ | — | | | $ | — | | | $ | 831 | | | $ | 831 | | Residential real estate | | — | | | — | | | 272 | | | 272 | | Total individually evaluated collateral dependent loans recorded at fair value | | $ | — | | | $ | — | | | $ | 1,103 | | | $ | 1,103 | | | | | | | | | | | MSRs | | $ | — | | | $ | 13,482 | | | $ | — | | | $ | 13,482 | | | | | | | | | | | OREO recorded at fair value: | | | | | | | | | Residential real estate | | — | | | — | | | 775 | | | 775 | | Total OREO recorded at fair value | | $ | — | | | $ | — | | | $ | 775 | | | $ | 775 | | | | | | | | | | | Other repossessed assets | | $ | — | | | $ | — | | | $ | 2,750 | | | $ | 2,750 | |
|
Schedule of impaired financing receivables additional info |
The following tables provide the amortized cost basis of collateral-dependent loans by class of loan, as of March 31, 2022 and December 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2022 | (In thousands) | | Real Estate | | Business Assets | | Other | Total | Commercial, financial and agricultural | | | | | | | | Commercial, financial and agricultural | | $ | 8,343 | | | $ | 13,742 | | | $ | 201 | | $ | 22,286 | | Commercial real estate | | 42,534 | | | 35 | | | — | | 42,569 | | Construction real estate: | | | | | | | | Commercial | | 1,152 | | | — | | | — | | 1,152 | | Residential real estate: | | | | | | | | Commercial | | 2,620 | | | 20 | | | — | | 2,640 | | Mortgage | | 366 | | | — | | | — | | 366 | | HELOC | | 124 | | | — | | | — | | 124 | | Leases | | — | | | 1,059 | | | — | | 1,059 | | Total loans | | $ | 55,139 | | | $ | 14,856 | | | $ | 201 | | $ | 70,196 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2021 | (In thousands) | | Real Estate | | Business Assets | | Other | Total | Commercial, financial and agricultural | | | | | | | | Commercial, financial and agricultural | | $ | 9,321 | | | $ | 13,366 | | | $ | 156 | | $ | 22,843 | | Commercial real estate | | 52,901 | | | 37 | | | — | | 52,938 | | Construction real estate: | | | | | | | | Commercial | | 1,178 | | | — | | | — | | 1,178 | | Residential real estate: | | | | | | | | Commercial | | 2,906 | | | — | | | 57 | | 2,963 | | Mortgage | | 370 | | | — | | | — | | 370 | | HELOC | | 148 | | | — | | | — | | 148 | | Leases | | — | | | 1,211 | | | — | | 1,211 | | Total loans | | $ | 66,824 | | | $ | 14,614 | | | $ | 213 | | $ | 81,651 | |
Interest income on nonaccrual loans individually evaluated for impairment is recognized on a cash basis only when Park expects to receive the entire recorded investment in the loans. Interest income on accruing TDRs individually evaluated for impairment continues to be recorded on an accrual basis. The following table presents interest income recognized on nonaccrual loans for the three-month periods ended March 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | Interest Income Recognized | (In thousands) | | Three Months Ended March 31, 2022 | | Three Months Ended March 31, 2021 | Commercial, financial and agricultural: | | | | | Commercial, financial and agricultural | | $ | 17 | | | $ | 57 | | PPP loans | | — | | | — | | Overdrafts | | — | | | — | | Commercial real estate | | 257 | | | 515 | | Construction real estate: | | | | | Commercial | | 1 | | | 33 | | Retail | | 4 | | | 1 | | Residential real estate: | | | | | Commercial | | 20 | | | 46 | | Mortgage | | 33 | | | 79 | | HELOC | | 4 | | | 4 | | Installment | | 2 | | | 1 | | Consumer: | | | | | Consumer | | 14 | | | 23 | | GFSC | | 2 | | | 5 | | Check loans | | — | | | — | | Leases | | 14 | | | 20 | | Total loans | | $ | 368 | | | $ | 784 | |
|
Qualitative Information about Level 3 Fair Value Measurements Measured on Non-Recurring Basis |
The following tables present qualitative information about Level 3 fair value measurements for financial instruments measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2022 | (In thousands) | | Fair Value | | Valuation Technique | | Unobservable Input(s) | | Range (Weighted Average) | Individually evaluated collateral dependent loans: | | | | | | | | | Commercial real estate | | $ | 566 | | | Sales comparison approach | | Adj to comparables | | 0.0% - 232.0% (22.8%) | | | | | | | | | | Residential real estate | | $ | 261 | | | Sales comparison approach | | Adj to comparables | | 0.5% - 78.6% (11.4%) | | | | | Cost approach | | Accumulated depreciation | | 8.3% (8.3%) | | | | | | | | | | Other real estate owned: | | | | | | | | | Residential real estate | | $ | 760 | | | Sales comparison approach | | Adj to comparables | | 5.0% - 32.5% (19.1%) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at December 31, 2021 | (In thousands) | | Fair Value | | Valuation Technique | | Unobservable Input(s) | | Range (Weighted Average) | Individually evaluated collateral dependent loans: | | | | | | | | | Commercial real estate | | $ | 831 | | | Sales comparison approach | | Adj to comparables | | 0.0% - 232.0% (28.3%) | | | | | | | | | | Residential real estate | | $ | 272 | | | Sales comparison approach | | Adj to comparables | | 0.5% - 78.6% (11.6%) | | | | | Cost approach | | Accumulated depreciation | | 8.3% (8.3%) | | | | | | | | | | Other real estate owned: | | | | | | | | | | | | | | | | | | Residential real estate | | $ | 775 | | | Sales comparison approach | | Adj to comparables | | 5.0% - 32.5% (19.1%) |
|
Fair Value, by Balance Sheet Grouping |
The fair value of certain financial instruments at March 31, 2022 and December 31, 2021, was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2022 | | | | | Fair Value Measurements | (In thousands) | | Carrying value | | Level 1 | | Level 2 | | Level 3 | | Total fair value | Financial assets: | | | | | | | | | | | Cash and money market instruments | | $ | 246,892 | | | $ | 246,892 | | | $ | — | | | $ | — | | | $ | 246,892 | | Investment securities (1) | | 1,757,147 | | | — | | | 1,757,147 | | | — | | | 1,757,147 | | Other investment securities (2) | | 2,037 | | | 1,546 | | | — | | | 491 | | | 2,037 | | | | | | | | | | | | | Mortgage loans held for sale | | 7,852 | | | — | | | 7,852 | | | — | | | 7,852 | | Mortgage IRLCs | | 301 | | | — | | | 301 | | | — | | | 301 | | Individually evaluated loans carried at fair value | | 827 | | | — | | | — | | | 827 | | | 827 | | Other loans, net | | 6,733,765 | | | — | | | — | | | 6,713,878 | | | 6,713,878 | | Loans receivable, net | | $ | 6,742,745 | | | $ | — | | | $ | 8,153 | | | $ | 6,714,705 | | | $ | 6,722,858 | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | Time deposits | | $ | 694,544 | | | $ | — | | | $ | 696,789 | | | $ | — | | | $ | 696,789 | | Other | | 2,770 | | | 2,770 | | | — | | | — | | | 2,770 | | Deposits (excluding demand deposits) | | $ | 697,314 | | | $ | 2,770 | | | $ | 696,789 | | | $ | — | | | $ | 699,559 | | | | | | | | | | | | | Short-term borrowings | | $ | 205,927 | | | $ | — | | | $ | 205,927 | | | $ | — | | | $ | 205,927 | | Subordinated notes | | 188,322 | | | — | | | 201,516 | | | — | | | 201,516 | | | | | | | | | | | | | Derivative financial instruments - assets: | | | | | | | | | | | Loan interest rate swaps | | 923 | | | — | | | 923 | | | — | | | 923 | | | | | | | | | | | | | Derivative financial instruments - liabilities: | | | | | | | | | | | Fair value swap | | 226 | | | — | | | — | | | 226 | | | 226 | | Borrowing interest rate swap | | 86 | | | — | | | 86 | | | — | | | 86 | | Loan interest rate swaps | | 923 | | | — | | | 923 | | | — | | | 923 | |
(1) Includes debt securities AFS. (2) Excludes FHLB stock and FRB stock which are carried at their respective redemption values, investment securities accounted for at modified cost as these investments do not have a readily determinable fair value, and Partnership Investments valued using the NAV practical expedient. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2021 | | | | | Fair Value Measurements | (In thousands) | | Carrying value | | Level 1 | | Level 2 | | Level 3 | | Total fair value | Financial assets: | | | | | | | | | | | Cash and money market instruments | | $ | 219,180 | | | $ | 219,180 | | | $ | — | | | $ | — | | | $ | 219,180 | | Investment securities (1) | | 1,754,140 | | | — | | | 1,754,140 | | | — | | | 1,754,140 | | Other investment securities (2) | | 2,129 | | | 1,630 | | | — | | | 499 | | | 2,129 | | | | | | | | | | | | | Mortgage loans held for sale | | 9,387 | | | — | | | 9,387 | | | — | | | 9,387 | | Mortgage IRLCs | | 333 | | | — | | | 333 | | | — | | | 333 | | Individually evaluated loans carried at fair value | | 1,103 | | | — | | | — | | | 1,103 | | | 1,103 | | Other loans, net | | 6,777,102 | | | — | | | — | | | 6,783,848 | | | 6,783,848 | | Loans receivable, net | | $ | 6,787,925 | | | $ | — | | | $ | 9,720 | | | $ | 6,784,951 | | | $ | 6,794,671 | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | Time deposits | | $ | 711,660 | | | $ | — | | | $ | 714,307 | | | — | | | $ | 714,307 | | Other | | 1,465 | | | 1,465 | | | — | | | — | | | 1,465 | | Deposits (excluding demand deposits) | | $ | 713,125 | | | $ | 1,465 | | | $ | 714,307 | | | $ | — | | | $ | 715,772 | | | | | | | | | | | | | Short-term borrowings | | $ | 238,786 | | | $ | — | | | $ | 238,786 | | | $ | — | | | $ | 238,786 | | Subordinated notes | | 188,210 | | | — | | | 207,912 | | | — | | | 207,912 | | | | | | | | | | | | | Derivative financial instruments - assets: | | | | | | | | | | | Loan interest rate swaps | | 1,952 | | | — | | | 1,952 | | | — | | | 1,952 | | | | | | | | | | | | | Derivative financial instruments - liabilities: | | | | | | | | | | | Fair value swap | | $ | 226 | | | $ | — | | | $ | — | | | $ | 226 | | | $ | 226 | | Borrowing interest rate swap | | 262 | | | — | | | 262 | | | — | | | 262 | | Loan interest rate swaps | | 1,952 | | | — | | | 1,952 | | | — | | | 1,952 | |
|
Impaired Financing Receivables at fair value |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2022 | (In thousands) | | Loan Balance | | Prior Charge-Offs | | Specific Valuation Allowance | | Carrying Balance | Total individually evaluated collateral dependent loans recorded at fair value | | $ | 970 | | | $ | 240 | | | $ | 143 | | | $ | 827 | | Remaining individually evaluated loans | | 62,239 | | | 384 | | | 1,370 | | | 60,869 | | Total individually evaluated loans | | $ | 63,209 | | | $ | 624 | | | $ | 1,513 | | | $ | 61,696 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2021 | (In thousands) | | Loan Balance | | Prior Charge-Offs | | Specific Valuation Allowance | | Carrying Balance | Total individually evaluated collateral dependent loans recorded at fair value | | $ | 1,291 | | | $ | 240 | | | $ | 188 | | | $ | 1,103 | | Remaining individually evaluated loans | | 73,211 | | | 384 | | | 1,428 | | | 71,783 | | Total individually evaluated loans | | $ | 74,502 | | | $ | 624 | | | $ | 1,616 | | | $ | 72,886 | |
|